Tools For Handling Mortgage-Based FCA Claims

Law360, New York (September 26, 2012, 2:19 PM EDT) -- Over the past two decades, many pharmaceutical and medical device companies have been the targets of False Claims Act (FCA) litigation. Many of these cases have focused on claims that a drug or device was marketed for off-label uses — that is, uses that were not previously approved by the U.S. Food and Drug Administration. The result has been numerous settlements of hundreds of millions, or even billions, of dollars.

Increasingly, the FCA, which was established in 1863 as a means to impose liability on those...
To view the full article, register now.